<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03811964</url>
  </required_header>
  <id_info>
    <org_study_id>6791</org_study_id>
    <nct_id>NCT03811964</nct_id>
  </id_info>
  <brief_title>Photomotor Reflex to Evaluate the Role of the Non-visual Effects of Light in Neurological, Psychiatric and Ophthalmological Pathologies</brief_title>
  <official_title>Study of the Photomotor Reflex to Evaluate the Role of the Non-visual Effects of Light in Neurological, Psychiatric and Ophthalmological Pathologies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The light has visual and non-visual effects on organism and can act on the behavior, the
      mood, the cognition and the sleep. These effects are mediated by &quot;classical&quot; retina
      photoreceptors which allow vision (rods, cones) but also melanopsin cells. The non-visual
      effects of light seems to be altered in many neurological, psychiatric or ophtalmological
      conditions but their exact role in the pathogenesis remains poorly understand. The purpose of
      the study is to increase our knowledge of the non-visual effects of light and establish new
      therapeutic applications
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 22, 2020</start_date>
  <completion_date type="Anticipated">February 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PIPR : Post-Illumination Pupil Response</measure>
    <time_frame>1 day</time_frame>
    <description>1 measurement per subject is performed after exposure to monochromatic light exposure</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">726</enrollment>
  <condition>Sleep Disorders</condition>
  <condition>Neurological Pathologies</condition>
  <condition>Psychiatric Pathologies</condition>
  <condition>Ophthalmological Pathologies</condition>
  <arm_group>
    <arm_group_label>primary sleep-wake disorder</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects with primary sleep-wake disorder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>neurological pathology</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subjects presenting a neurological pathology with disorder of the controls of the wake and the sleep</description>
  </arm_group>
  <arm_group>
    <arm_group_label>psychiatric pathology</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subject presenting a psychiatric pathology with disorder of the controls of the wake and the sleep</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ophthalmological pathology</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subject presenting an ophthalmological pathology with possible alteration of the photoreception and / or phototransduction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>photosensitivity</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subjects with photosensitivity with regulation disorder of sleep and wake</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>healthy subject</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Specific light exposures</intervention_name>
    <description>Specific light exposures using light in a wide range of intensities or different light/dark regimens</description>
    <arm_group_label>group control</arm_group_label>
    <arm_group_label>neurological pathology</arm_group_label>
    <arm_group_label>ophthalmological pathology</arm_group_label>
    <arm_group_label>photosensitivity</arm_group_label>
    <arm_group_label>primary sleep-wake disorder</arm_group_label>
    <arm_group_label>psychiatric pathology</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or woman

          -  Aged 18 years or older

          -  Subject having signed a free and informed consent

          -  Subject affiliated to a social protection scheme Arm 1 :Subjects with primary
             sleep-wake disorder Arm 2 : subjects presenting a neurological pathology with disorder
             of the controls of the wake and the sleep Arm 3 : subject presenting a psychiatric
             pathology pathology with disorder of the controls of the wake and the sleep Arm 4 :
             subject presenting an ophthalmological pathology with possible alteration of the
             photoreception and / or phototransduction Arm 5 : subjects with photosensitivity with
             regulation disorder of sleep and wake Arm 6 : healthy subject

        Exclusion Criteria:

        Age-Related Macular Degeneration (AMD) and all maculopathies (retinopathies pigmentosa,
        macular involvement of diabetes)

          -  Cataract with significant vision loss &lt;5/10

          -  Chorioretinal neovascularization

          -  Subject in exclusion period determined by previous or current study

          -  Impossibility to give the subject information enlightened (subject in emergency
             situation, difficulties of understanding the subject, ...)

          -  Subject under the protection of justice

          -  Subject under guardianship or curatorship

          -  Pregnancy / Breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bourgin Patrice, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bourgin Patrice, MD</last_name>
    <phone>03 88 11 64 30</phone>
    <phone_ext>0033</phone_ext>
    <email>pbourgin@unistra.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital, Strasbourg, France</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bourgin Patrice, MD</last_name>
      <phone>03 88 11 64 30</phone>
      <phone_ext>0033</phone_ext>
      <email>pbourgin@unistra.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>January 9, 2019</study_first_submitted>
  <study_first_submitted_qc>January 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2019</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Wake Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

